Recent BCYC Stock Price | BCYC Stock Predictions | |
$24.69 | +76.39% |
$43.55 |
Recent BCYC Analyst Ratings Breakdown, Making BCYC Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 10 | 10 | 10 | 10 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.25 | 1.25 | 1.25 | 1.25 |
For the BCYC stock predictions from the analysts covering Bicycle Therapeutics plc, we have collected all of the individual BCYC stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering BCYC (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since BCYC stock predictions may vary widely, another useful metric to consider is the median BCYC stock prediction, which represents the price at which half of the analysts
made BCYC stock predictions that were higher and half made BCYC stock predictions that were lower. This makes for a different take on the BCYC stock predictions out there, as compared to average or mean.
And that median across all the individual BCYC stock predictions was: $43.0 as of 2024-05-03.
The very highest of the BCYC stock predictions for one year price target was $60.0, while the very lowest of the BCYC stock predictions in the analyst group was
$30.0 (with a standard deviation of $11.609). Get the latest Zacks research report on BCYC — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
MOMO Stock Predictions
CZNC Stock Predictions
IDRA Stock Predictions
ISRG Stock Predictions
PGEN Stock Predictions
JBGS Stock Predictions
AVGO Stock Predictions
NRG Stock Predictions
GLOG Stock Predictions
|
|
Strong Buy (3.75 out of 4) 72nd percentile
(ranked higher than approx. 72% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |